Assessment of adherence measures with different stimulants among children and adolescents. - Wikidata - awgldk - TriplyDB

Assessment of adherence measures with different stimulants among children and adolescents.

Assessment of adherence measures with different stimulants among children and adolescents.

http://www.wikidata.org/entity/Q46592039

about

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review Emerging support for a role of exercise in attention-deficit/hyperactivity disorder intervention planning Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine.Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficit/hyperactivity disorder.The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: can we alter the developmental trajectory of ADHD?Exasperating or exceptional? Parents' interpretations of their child's ADHD behavior.Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences.Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.The NICE ADHD health technology assessment: a review and critique Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient Records Injury among stimulant-treated youth with ADHD.Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia.Review of medication adherence in children and adults with ADHD.The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?Enhanced Physical Activity Improves Selected Outcomes in Children With ADHD: Systematic Review.ADHD medication vacations and parent-child interactions by gender.Medication adherence in psychopharmacologically treated adults with ADHD.Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning.Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.Les médicaments à libération prolongée pour les enfants et les adolescents ayant un trouble de déficit de l’attention avec hyperactivité.Training executive, attention, and motor skills: a proof-of-concept study in preschool children With ADHD.Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.Predictors of medication adherence in children receiving psychotropic medication.Medication Adherence and Symptom Reduction in Adults Treated with Mixed Amphetamine Salts in a Randomized Crossover Study

P2860

Q26822392-F106A891-E7B1-4CA4-A070-6DAEE4560D95 Q26859455-B8CFD238-FB19-4665-B6A1-1F28865A5879 Q26866477-93437418-F31D-4775-BB77-E4222C6E5083 Q33571016-A81A4504-8E96-4F3E-AA86-FDCF5C7CCEBB Q33571522-AC0A6A72-24F5-4E19-BCA7-DFBC9DBF37F6 Q33588902-AB3F2985-18F8-4FC8-B137-8B665EAAA578 Q34112093-E973CA6F-E2F9-4007-AC4B-BB9818585E67 Q34130151-08069E85-B7A3-41B6-BB5F-86255704008C Q34240468-D263351E-4E52-4D0B-95C1-1BDA034BF569 Q34286130-C05AAF47-318E-43F3-80BC-F668DA3439DC Q34554876-2F901191-0ACF-48D2-A78F-EB379A83621F Q34647061-0D9F25A2-7484-4B8F-A2D1-74335560C020 Q34974158-4AE79699-A3BD-4220-BE11-0364DCFEECA7 Q35123049-C92BA0E5-AA1E-4D9A-9529-60D385837776 Q36029110-18C23F0F-0A18-4011-8688-14D52C71B241 Q36409734-4F7D2A0F-A853-4503-8662-CC898E35E951 Q36491460-4BD103DA-EA62-43D1-BCCC-7D18F0932660 Q36731199-FD3FECD6-3D36-44E1-8233-1E32CD8DEC3D Q36787283-46365764-EB92-498A-A9A3-43226E08F8E0 Q36925773-61D73DD2-20B8-4A94-A9E5-1D81BCA7EDEE Q36969976-D4EEBB6E-491F-4CD6-892D-7F166863193F Q37225350-3CE9FD61-7B18-494E-87FA-8A94E4E38E13 Q37682563-597D77FB-A7CD-4B88-89C6-8253CC68A3A9 Q37983613-B0D4BAD1-9F89-4599-A73A-375FFB6F6F11 Q38844566-BCE09A88-48DA-46FD-8551-262B63DBAE0F Q39648052-97AB8864-0097-41A4-920C-994FF6244134 Q40249612-3AE3F930-8B27-47B3-8FB0-886D9A08CCE3 Q40400512-6D5D9DF0-BE1B-436A-94C6-CA28095BAACE Q42654528-5FD29925-914A-4C8F-BB3F-4020E5413225 Q44103911-BEAAB739-9785-498F-9FAE-2ECAF0022A40 Q47322558-2B7E50C3-D9E7-4729-BB17-A67EF0D0912C Q47577155-DA096A38-29CD-4945-B0A6-1B7812136436 Q48283852-42FB0C26-E72E-41A3-B27E-4AD19AA64285 Q48353565-03FF6345-C6CE-45DD-960E-48EEB7A7EC00 Q51814904-8594695B-2BD8-4A0B-B6FA-42D91B3BD87C Q57399839-6E3ED4FB-40EC-491F-8642-FA05E1FC9741

P2860

Assessment of adherence measures with different stimulants among children and adolescents.

http://www.wikidata.org/entity/Q46592039

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Assessment of adherence measur ...... mong children and adolescents.

@en

Assessment of adherence measur ...... mong children and adolescents.

@nl

type

label

Assessment of adherence measur ...... mong children and adolescents.

@en

Assessment of adherence measur ...... mong children and adolescents.

@nl

prefLabel

Assessment of adherence measur ...... mong children and adolescents.

@en

Assessment of adherence measur ...... mong children and adolescents.

@nl

P1433

Q46592039-83EADBC7-65BB-4E76-A0D3-C20F2BF86FB7

P1476

Q46592039-B78B98AB-D556-4DAD-8501-37F8869D7463

P2093

Q46592039-CE552CB1-FE28-46AE-86E7-73E009C59653

Q46592039-CE9AB09B-A2C0-45FF-B99A-9177A1989AFB

Q46592039-D7F93152-04B1-44DA-87A8-9B362C4BF24C

Q46592039-E5FEED25-041B-4DED-8191-549FB001D36D

Q46592039-FDDF0A6E-97A8-420D-B79B-41402C54D858

P2860

Q46592039-01D82582-2E66-456E-AF8F-9B8A9C6A2A95

Q46592039-0667E9E1-F867-48E1-AAEF-110233A36272

Q46592039-0D91139B-DC3C-4AB7-9F1B-ABCD874EE492

Q46592039-148FAB75-4C1D-4D43-9E4F-7E228940A45E

Q46592039-263D9D28-F8D6-4215-93E2-1FA99A213CD2

Q46592039-2A5DACCD-E913-4151-A7C4-C2AFABA6F9F2

Q46592039-30BA8CE9-B51D-4AD5-BE2B-EAFF1EBAA499

Q46592039-335177C2-0984-41EC-A1C7-286D62173F56

Q46592039-44E41693-7C0C-4029-AD67-CFAEC2BA5AB8

Q46592039-4DE5A5BF-34E9-468B-85C2-167588D1C8BA

P304

Q46592039-1D50C0C1-5BFC-4063-AC59-2B057DDABB78

P31

Q46592039-64E3DBE1-CBEE-42AA-AFE1-8B2593204725

P356

Q46592039-D325E567-95AF-4216-A04B-90D0F852C9D9

P407

Q46592039-D05EE204-9C1D-4302-AAB2-1AEDEEA2279D

P433

Q46592039-708B6B22-77A3-4AF9-BAD5-56D80B9FC25C

P478

Q46592039-95A975C9-85AA-45BC-A8F5-3BF394CE011D

P577

Q46592039-73F6326A-F683-4D94-A8F5-7715AD832D5C

P5875

Q46592039-42C04003-B6CB-4F3D-A82F-77A870B0AF6C

P698

Q46592039-052BEF5F-CB35-4E46-AAC9-EBFD873D21A5

P921

Q46592039-16BB363F-1505-45D6-A1E3-E9E9E3ADF9D4

P356

PHCO.2005.25.7.909

P1433

Pharmacotherapy

P1476

Assessment of adherence measur ...... mong children and adolescents.

@en

P2093

James P Wilson

http://www.w3.org/2001/XMLSchema#string

Jamie C Barner

http://www.w3.org/2001/XMLSchema#string

M Lynn Crismon

http://www.w3.org/2001/XMLSchema#string

Robert J Sanchez

http://www.w3.org/2001/XMLSchema#string

Tawny Bettinger

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

Predictors of medication-refill adherence in an indigent rural population.

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

A systematic review of the associations between dose regimens and medication compliance.

Trends in the prescribing of psychotropic medications to preschoolers.

Enhancing drug compliance in lipid-lowering treatment.

Patient adherence to treatment: three decades of research. A comprehensive review.

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

A review of the literature on the economics of noncompliance. Room for methodological improvement.

P304

909-917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.2005.25.7.909

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7738808

http://www.w3.org/2001/XMLSchema#string

P698

16006269

http://www.w3.org/2001/XMLSchema#string

P921